Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Min
Weill Medical Coll of Cornell Univ, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
MDDX
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
MDDX provides services to perform research applications and solutions for clinical trials and performs imaging informatics to facilitate the management of multicenter, international clinical trials in the Weill Cornell Dalio Institute of Cardiovascular Imaging. MDDX is a nonpublicly traded entity. Dr. James Min is the co-founder of MDDX with (b)(4) ownership and he is also the director of the Dalio Institute. Dr. Min is using MDDX's services for this research project. While MDDX's services are not the subject of the research, it is providing services to facilitate the performance of the research such as de-identifying data and could be seen as affecting the conduct of the research creating a perceived conflict of interest for Dr. Min.
Gender-Specific Coronary Plaque Characteristics and Risk of Myocardial Infarction
For women and men who are at risk of developing heart attacks, the study of patients with coronary artery disease (CAD) has traditionally been focused on severity of blockages, rather than coronary plaque characteristics, or the makeup of blockages in heart arteries. Computed tomography (CT) scans of the heart now allow for non-invasive evaluation of coronary plaque characteristics. This study will evaluate the specific makeup of coronary plaque by gender and determine its relationship to risk of future heart attacks, which may redefine the diagnostic approach to women and men with suspected CAD.
Filed on April 20, 2016.
Tell us what you know about James Min's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
James Min filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James Min | Weill Medical Coll of Cornell Univ | Conflict of Interest | HeartFlow, Inc. | $0 - $4,999 |
| James Min | Weill Medical Coll of Cornell Univ | Conflict of Interest | HeartFlow, Inc. | $0 - $4,999 |
| James Min | Weill Medical Coll of Cornell Univ | Conflict of Interest | HeartFlow, Inc. | Value cannot be readily determined |
| James Min | Weill Medical Coll of Cornell Univ | Conflict of Interest | MDDX | Value cannot be readily determined |
| James Min | Weill Medical Coll of Cornell Univ | Conflict of Interest | MDDX | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.